Survival and recurrence in the multidisciplinary approach of colorectal cancer;Supervivencia y recidiva en el tratamiento multidisciplinario del carcinoma colorrectal

Medicina Clinica

Volumn 123, Issue 8, 2004, Pages 291-296

  Martí Ragué, Juan ^a   Parés, David ^a   Biondo, Sebastiano ^a   Navarro, Matilde ^b   Figueras, Juan ^a   De Oca, Javier ^a   Pareja, Laura ^c   Cambray, Maria ^b   Río, Carlos Del ^a   Osorio, Alfonso ^a   Novell, Valeri ^a   Jaurrieta, Eduardo ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c Servcio Epidemiologia I Registro C   (Spain)

Author keywords

Colorectal cancer; Recurrence; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 5644231021     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(04)74495-4     Document Type: Article

References (34)

1. Wu JS, Fazio VW. Colon cancer. Dis Colon Rectum 2000;43:1473-86.
2. Ortiz H. Tratamiento quirúrgico y resultados del cáncer de colon. Cir Esp 2003;73:1-2.
3. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJC. Population-based audit of colorectal cancer management in two UK health regions. Br J Surg 1997;84:1731-6.
4. RCSE (Royal College of Surgeons of England) and ACGBI (Association of Coloproctology of Great Britain an Ireland). Guidelines for the management of colorectal cancer, 1996.
5. th ed. New York: Wiley-Liss, 1997; p. 66-9.
6. Fernández E, González JR, Borràs JM, Sánchez V, Moreno V, Peris M. Evolución de la mortalidad por cáncer en Cataluña (1975-1998). Med Clin (Barc) 2001;116:605-9.
7. Chen HS, Sheen-Chen SM. Obstruction and perforation in colorectal adenocarcinoma: An analysis of prognosis and current trends. Surgery 2000;127:370-6.
8. Romero M, Alós R, Aparicio J, Estevan R, García J, Grau E, et al. Resumen de la guía de práctica clínica en el cáncer colorrectal de la Sociedad Valenciana de Cirugía. Cir Esp 1999;65:326-30.
9. Nogueras JJ, Jagelman DG. Principles of surgical resection. Influence of surgical technique on treatment outcome. Surg Clin North Am 1993; 73:103-16.
10. Biondo S, Martí-Ragué J. Cáncer colorrectal. ¿Qué factores pueden ser determinantes en su curación o recidiva? Cir Esp 2001;70:265-6.
11. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery. The clue to pelvic recurrence? Br J Surg 1982;69:613-6.
12. García-Granero E, Martí-Obiol R, Gómez-Barbadillo J, García-Armengol J, Esclapez P, Espí A, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorec Dis 2001;3:179-84.
13. Runkel NS, Hinz U, Lehnert T Buhr HJ, Herfarth CH. Improved outcome after emergency surgery for cancer of the large intestine. Br J Surg 1998;85:1260-5.
14. Beart RW, Steele GD, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the comission on cancer. J Am Coll Surg 1995;181:225-36.
15. Allum WH, Slanley G, McConkey CC, Powell J. Cancer of the colon and rectum in the West Midlands, 1957-1981. Br J Surg 1994;81:1060-3.
16. Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195:33-40.
17. Gérard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208:606-14.
18. Frykholm JG, Glimelius B, Pählam L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of randomized trial and evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-72.
19. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
20. Martling A, Holm T, Johansson H, Rutqvist LE, Cedemark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902.
21. Halvorsen TB, Seim E. Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J Clin Pathol 1988;41:532-7.
22. Talbot IC, Ritchie S, Leigthon M, Hughes AO, Bussey HJR, Morson BC. Invasion of veins by carcinoma of the rectum: method of detection, histological features and significance. Histopathology 1981;5:141-63.
23. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:110-24.
24. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet 1987; 1:1303-6.
25. Bruinvels DJ, Stiggelbout AM, Kievit J, Van Houwelingen HC, Habbema DF, Van de Velde CJH. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219: 174-82.
26. Wanebo HJ, Gaker DL, Whitehall R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 1987;205:482-95.
27. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996;83:293-304.
28. Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996;39:730-6.
29. Figueras J, Torras J, Valls C, Lama C, Navarro M, Martí- Ragué J, et al. Factores pronósticos e indicaciones quirúrgicas en las metástasis hepáticas de carcinoma colorrectal. Rev Oncología 2000;6:309-15.
30. Choti MA, Bowman HM, Pitt HA, Sosa JA, Sitzman JV, Cameron JL, et al. Should hepatic resections be performed at high volume referral centers? Gastrointest Surg 1998;2:11-20.
31. Cubillo A, De Castro J, Feliu J, González Barón M. Estado actual del tratamiento de las metástasis hepáticas de carcinoma colorrectal. Med Clin (Barc) 2000;114:506-10.
32. Valls C, López E, Guma A, Gil M, Sánchez A, Andia E, et al. Helical CT vs CTAP in the detection of liver metastases from colorrectal carcinoma. Am J Roentgenol 1998;170:1341-7.
33. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001;88:980-5.
34. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.